Diabetes Clinical Trials in Maryland

Showing 601-620 of 659 trials

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

NCT01415115

The trial is designed as a feasibility study to determine the correlation of noninvasive measurements of AGE with the SCOUT device to diabetes complications.

Type 1 DiabetesType 2 Diabetes

VeraLight, Inc.250 participantsStarted Mar 2007

Hyattsville, Maryland, United States

TERMINATEDPhase 312 miles

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

NCT00226330

This is a parallel-group, multi-center, long-term extension study from the GALLANT 6 study to monitor the safety and tolerability of oral tesaglitazar compared with pioglitazone in patients with type 2 diabetes for up to 104 weeks of treatment. The total duration, including treatment and follow-up, is 107 weeks.

Diabetes Mellitus, Type 2

AstraZeneca1,100 participantsStarted Mar 2005

Birmingham, Alabama, United States • Columbiana, Alabama, United States • Mobile, Alabama, United States +168 more locations

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

Culturally Tailored Behavioral Diabetes Care Intervention for Korean Americans

Dose Ranging Study With LT, Monotherapy, PPAR

GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

A Study for Patients With Type 2 Diabetes Mellitus

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

PPAR-COMBO With Sulfonylurea

Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms

GALLANT 6 Tesaglitazar vs. Pioglitazone

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Post-PCI:Cardiac Imaging in Patients With Diabetes to Detect Coronary Artery Blockages Previously Opened by Angioplasty

A Study in Patients With Type 2 Diabetes

A Study for Type 2 Diabetic Patients

DPBRN Blood Sugar Testing in Dental Patients

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes

Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes

Other Conditions in Maryland